Home | Sign Up | Log In | Browse Users | Contact Us | Help | Ripside Inc.
View with default template | Who's Here?
marketspeculator
Member Since: 8/11/2008 6:25:43 AM
Last Seen: 9/9/2008 8:58:57 AM


Send private message
Invite to Friend Network
Photo Album

About Me

Age:
Gender:
Location:

My Friends
marketspeculator has 0 friends. View all of marketspeculator's friends.

Posted 8/30/2008 7:10:04 AM
Celegene Corporation has its modest start to their present position in the worldwide culturally diverse and integrated biopharmaceutical company. Celgene Corporation has 1,600 employees globally; they are committed to patients around the globe. Celgene is a multi-national biopharmaceutical company that is aiming to improve the lives of patients globally. The shares of stocks of Celgene Corporation in the NYSE according to AOL money and finance are 75.15%, the stocks increase by 1.35% up to 1.83%.

Celgene Corporation delivers truly inventive and life-changing drugs for their patients. Their mission as an organization is to establish a major worldwide biopharmaceutical institution while putting all their efforts on the development, discovery and the industrialization of products for the treatment of severe immune, inflammatory conditions and cancer.

There are many clinical tests and trials at major medical centres utilizing the compositions from Celgene. There are investigational components are being examined for patients with solid tumour cancers like , myelodysplastic syndromes, lymphocyte leukemia (CLL), multiple myeloma chronic non-Hodgkin's lymphoma (NHL), glioblastoma, and ovarian, pancreatic and prostate cancer. The company is committed to achieve clinical success while supporting patients with their guiding principles. They believe all patients can benefit from their innovative biopharmaceutical products like REVLIMID (lenalidomide), an FDA approved medicine that helps patients with anemia, Thalomid (thalidomide), FDA approved phramceutical product that treats patients with multiple myeloma and Alkeran (melphalan), a medicine used in theraphy for multiple myeloma, though this product was licensed from Glaxosmithkline.

(0) Comments


Posted 8/11/2008 6:27:37 AM
Dominion Resources, Inc is one company that is known in the energy transportation market. Tucked under the belt of the company are assets that include 26,500 megawatts of generation, another 6,000 miles for electric transmission and another 55,000 miles of electric distribution lines that are located in North Carolina and Virginia. The company has a stake in gas and gas production as well with its 14,000 miles of natural gas transmission, storage and gathering and another 28,000 miles of pipeline that is used for gas distribution. Dominion also has 1.1 trillion cubic feet equivalent of gas and oil reserves. From these facts alone, the company can be best seen as one of the leading lights in its field.
The company’s operation is divided into three sectors and these include the Dominion Virginia Power, the Dominion Generation and the Dominion Energy. By the end of 2007, the company served more than 1.6 million residential and commercial customers that are based in the Northeastern part of the US, the mid-Atlantic part of the country and also the Midwestern part of the US. Since the company is one of the leading lights when it comes to energy generation and energy distribution, the company is always active in the stock market. The company is one of the most traded stocks in the market and it’s due to the fact that oil and energy has increasingly become an important and critical sector. Making a gamble on energy companies like Dominion should be taken seriously. If a would-be investor wants to finance the buying of a stock or has plans of investing, it’s best that a guide in the form of the stock trading software and the stock market software should be used.

(0) Comments


Archives
August, 2008

Calendar

Blog Categories
All Categories

General Comments

Please login to post a comment.

NewBlog.com is a free blogging service provided by Ripside Interactive, Inc.